Richard Knox

Since he joined NPR in 2000, Knox has covered a broad range of issues and events in public health, medicine, and science. His reports can be heard on NPR's Morning Edition, All Things Considered, Weekend Edition, Talk of the Nation, and newscasts.

Among other things, Knox's NPR reports have examined the impact of HIV/AIDS in Africa, North America, and the Caribbean; anthrax terrorism; smallpox and other bioterrorism preparedness issues; the rising cost of medical care; early detection of lung cancer; community caregiving; music and the brain; and the SARS epidemic.

Before joining NPR, Knox covered medicine and health for The Boston Globe. His award-winning 1995 articles on medical errors are considered landmarks in the national movement to prevent medical mistakes. Knox is a graduate of the University of Illinois and Columbia University. He has held yearlong fellowships at Stanford and Harvard Universities, and is the author of a 1993 book on Germany's health care system.

He and his wife Jean, an editor, live in Boston. They have two daughters.

Pages

Shots - Health News
4:27 pm
Mon August 19, 2013

Lyme Disease Far More Common Than Previously Known

Black-legged ticks like this can transmit the bacterium that causes Lyme disease.
CDC

Originally published on Mon August 19, 2013 5:58 pm

The Centers for Disease Control and Prevention says 300,000 Americans are getting Lyme disease every year, and the toll is growing.

"It confirms what we've thought for a long time: This is a large problem," Dr. Paul Mead tells Shots. "The bottom line is that by defining how big the problem is we make it easier for everyone to figure out what kind of resources we have to use to address it."

Read more
Shots - Health News
4:27 pm
Wed August 14, 2013

Evidence Supports Pill To Prevent Some Prostate Cancers

The active ingredient in Propecia, a baldness remedy approved by the Food and Drug Administration in 1997, is showing new promise as a way to prevent some prostate cancers.
AP

Originally published on Fri August 16, 2013 7:40 am

Researchers say a cheap, generic pill called finasteride prevents almost 40 percent of low-grade prostate cancers without increasing the risk of dying from more aggressive tumors.

New evidence points to the drug as a potentially safer way to deal with prostate cancers that now get more intense treatment. Many prostate cancers that aren't destined to cause men serious health problems are often treated with surgery or radiation.

Read more
Shots - Health News
2:34 pm
Wed July 31, 2013

Nurse Charged With Assisting In Her Father's Death

Barbara Mancini with her father, Joe Yourshaw.
Barbara Mancini via Compassion & Choices

Originally published on Wed July 31, 2013 5:22 pm

A Philadelphia nurse has been charged with assisted suicide for allegedly providing her 93-year-old father with a lethal dose of morphine.

Authorities say Barbara Mancini, 57, told a hospice nurse and a police officer on Feb. 7 that she provided a vial of morphine to her father, Joe Yourshaw, to hasten his death.

Mancini and her attorneys acknowledge she handed the medication to her father, but maintain she never said she intended to help him end his life and was only trying to help her father ease his pain — an act they say is legally protected, even if it causes death.

Read more
Shots - Health News
5:09 pm
Mon July 29, 2013

Panel Urges Lung Cancer Screening For Millions Of Americans

Some images of lung cancer are clear cut. But in many others, a nodule on the screen turns out not to be cancer at all.
iStockphoto.com

Originally published on Thu August 22, 2013 1:24 pm

A federal task force is planning to recommend that millions of smokers and former smokers get a CT scan annually to look for early signs of lung cancer.

The 16-member US Preventive Services Task Force gives that lung cancer screening test a grade of B, which puts it on the same level as mammography for women between the ages of 50 and 74.

Read more
Shots - Health News
1:58 pm
Fri July 19, 2013

HPV Vaccination Might Help Reduce Risk Of Throat Cancers

Vaccines against the HPV virus are already used to prevent cervical and anal cancer.
Harry Cabluck AP

Originally published on Tue July 23, 2013 3:29 pm

A study of women in Costa Rica is raising hope that getting vaccinated against the human papillomavirus, or HPV, could lower the risk of throat cancers.

The research doesn't show that. It would take a much bigger and longer study to do that – if such a study could ethically be done at all.

What this study does show is that among the nearly 6,000 women in the study, those who got vaccinated against two strains of the virus had 93 percent fewer HPV throat infections four years later.

Read more

Pages